RecruitingNot ApplicableNCT06844045

Point of Care STI Testing

Clinical and Implementation Outcomes of a Point of Care Sexually Transmitted Infection Testing Strategy to Improve HIV Prevention Service Delivery in Adolescents


Sponsor

Icahn School of Medicine at Mount Sinai

Enrollment

6,460 participants

Start Date

Feb 24, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The proposed research hypothesizes that point-of-care testing (POCT) for sexually transmitted infections (STIs) gonorrhea and chlamydia will be a feasible, acceptable, and appropriate implementation strategy for improving HIV testing and Pre-exposure prophylaxis (PrEP) delivery in youth, by increasing opportunities for clinician-patient counseling, decreasing loss to follow up, and allowing for same-day HIV prevention service provision. This hypothesis will be tested in a pragmatic non-randomized trial comparing clinical (HIV testing and PrEP counseling and prescription) and implementation (feasibility, acceptability, and appropriateness) outcomes between adolescents receiving POCT compared to laboratory-based testing at three clinics within a large pediatric health system.


Eligibility

Min Age: 16 YearsMax Age: 24 Years

Inclusion Criteria1

  • \- Patients age 16-24 years receiving POCT or lab-based GC/CT testing

Exclusion Criteria1

  • \- Patients with known HIV or active PrEP prescriptions.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALGonorrhea/chlamydia Point-of-Care Testing

Point-of-care testing for sexually transmitted infections.


Locations(1)

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06844045